The University of Oxford has launched the first study to assess the safety and immune responses in children and young adults of its coronavirus vaccine. The university said that previous trials of......
Backing the 12-16 weeks gap between the two doses of Covishield in the country, the chief investigator of the AstraZeneca vaccine clinical trials on Friday said that the level of protection......
A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......
The coronavirus vaccine developed by Oxford University and AstraZeneca shows promise as it can generate both antibodies and cell-mediated immune responses, say several scientists in India and......
'This year there is a sharp spike in fever cases, and it seems to be more than the pre-COVID-19 levels.' *IMAGE: The rise in fever cases are being reported at a time when Covid cases are also......
Probiotics, the new generation biotech drugs and dietary supplements developed from yeast or lactic acid bacteria, is emerging as a major opportunity in the domestic and international markets for......